Investors Research Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$157K Hold
846
0.03% 333
2025
Q1
$177K Buy
846
+105
+14% +$22K 0.04% 307
2024
Q4
$132K Hold
741
0.03% 355
2024
Q3
$146K Hold
741
0.03% 348
2024
Q2
$127K Hold
741
0.03% 373
2024
Q1
$135K Sell
741
-1,233
-62% -$225K 0.03% 367
2023
Q4
$306K Hold
1,974
0.07% 274
2023
Q3
$294K Hold
1,974
0.08% 272
2023
Q2
$266K Buy
1,974
+17
+0.9% +$2.29K 0.07% 293
2023
Q1
$312K Hold
1,957
0.08% 270
2022
Q4
$316K Hold
1,957
0.09% 263
2022
Q3
$263K Buy
1,957
+22
+1% +$2.96K 0.08% 270
2022
Q2
$296K Buy
1,935
+287
+17% +$43.9K 0.09% 259
2022
Q1
$267K Sell
1,648
-13,487
-89% -$2.19M 0.08% 281
2021
Q4
$2.05M Hold
15,135
0.62% 39
2021
Q3
$1.63M Hold
15,135
0.55% 46
2021
Q2
$1.71M Buy
15,135
+59
+0.4% +$6.65K 0.59% 38
2021
Q1
$1.63M Sell
15,076
-275
-2% -$29.8K 0.61% 22
2020
Q4
$1.65M Sell
15,351
-100
-0.6% -$10.7K 0.65% 17
2020
Q3
$1.35M Sell
15,451
-300
-2% -$26.3K 0.66% 19
2020
Q2
$1.55M Buy
15,751
+98
+0.6% +$9.62K 0.78% 14
2020
Q1
$1.19M Sell
15,653
-50
-0.3% -$3.81K 0.74% 12
2019
Q4
$1.39M Sell
15,703
-25
-0.2% -$2.21K 0.64% 17
2019
Q3
$1.19M Sell
15,728
-150
-0.9% -$11.4K 0.6% 23
2019
Q2
$1.16M Buy
15,878
+13,825
+673% +$1.01M 0.6% 27
2019
Q1
$165K Buy
+2,053
New +$165K 0.09% 294